acetaminophen glucuronide has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| A-Kader, HH; Bataille, AM; Campion, SN; Canet, MJ; Cherrington, NJ; Erickson, RP; Ferreira, DW; Hardwick, RN; Manautou, JE; Merrell, MD; Xanthakos, SA | 1 |
| Barshop, NJ; Capparelli, EV; Lavine, JE; Schwimmer, JB; Sirlin, CB | 1 |
2 other study(ies) available for acetaminophen glucuronide and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Bile Canaliculi; Biotransformation; Child; Cohort Studies; Fatty Liver; Female; Humans; Liver; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Non-alcoholic Fatty Liver Disease; Pilot Projects; Protein Transport; Up-Regulation | 2015 |
Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.
Topics: Acetaminophen; Adolescent; Case-Control Studies; Child; Fatty Liver; Glucuronosyltransferase; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Statistics, Nonparametric | 2011 |